Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Oct 15;391(Pt 2):177-84.
doi: 10.1042/BJ20050885.

NuMA is a major acceptor of poly(ADP-ribosyl)ation by tankyrase 1 in mitosis

Affiliations

NuMA is a major acceptor of poly(ADP-ribosyl)ation by tankyrase 1 in mitosis

William Chang et al. Biochem J. .

Abstract

Tankyrase 1 is a PARP [poly(ADP-ribose) polymerase] that localizes to multiple subcellular sites, including telomeres and mitotic centrosomes. Previous studies demonstrated that cells deficient in tankyrase 1 suffered a block in resolution of sister telomeres and arrested in early anaphase [Dynek and Smith (2004) Science 304, 97-100]. This phenotype was dependent on the catalytic PARP activity of tankyrase 1. To identify critical acceptors of PARsylation [poly(ADP-ribosyl)ation] by tankyrase 1 in mitosis, tankyrase 1 immunoprecipitates were analysed for associated PARsylated proteins. We identified NuMA (nuclear mitotic apparatus protein) as a major acceptor of poly(ADP-ribose) from tankyrase 1 in mitosis. We showed by immunofluorescence and immunoprecipitation that association between tankyrase 1 and NuMA increases dramatically at the onset of mitosis, concomitant with PARsylation of NuMA. Knockdown of tankyrase 1 by siRNA (small interfering RNA) eliminates PARsylation of NuMA in mitosis, confirming tankyrase 1 as the PARP responsible for this modification. However, even in the absence of tankyrase 1 and PARsylation, NuMA localizes to spindle poles. By contrast, siRNA knockdown of NuMA results in complete loss of tankyrase 1 from spindle poles. We discuss our result in terms of a model where PARsylation of NuMA by tankyrase 1 in mitosis could play a role in sister telomere separation and/or mitotic progression.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Tankyrase 1 is modified in mitosis
(A, B) Analysis of staged cell cycle extracts shows a mitosis-specific mobility shift in tankyrase 1. Following arrest in S phase by a double thymidine block, HeLaI.2.11 cells were released into nocodazole for 12 h, collected by shake-off and released out of nocodazole for 3 h. (A) FACS analysis of staged extracts: y axis, cell numbers; x axis, relative DNA content based on propidium iodide staining. (B) Immunoblot analysis of staged cell extracts generated in buffer C. Products were detected with anti-tankyrase 1 antibody 465 (TNKS1), anti-cyclin A, anti-cyclin B or anti-β-actin antibodies. Cell cycle stages S, G2/M and G1 as determined by FACS (A) are indicated. (C) The tankyrase 1 mobility shift is due to phosphorylation. Extracts generated in TNE buffer from asynchronous (asy) or nocodazole (noc)-arrested cells were immunoprecipitated (IP) with anti-tankyrase 1 antibody 465, incubated with (+) or without (−) λ-phosphatase and products detected by immunoblotting with anti-tankyrase 1 465 (TNKS1). (D) Mitotic tankyrase 1 does not show an increase in autoPARsylation. Tankyrase 1 was immunoprecipitated as in (C) and incubated in a PARP assay with [32P]NAD+. Products were detected by immunoblotting with anti-tankyrase 1 antibody 465 (TNKS1; upper panel) or by autoradiography (32P-ADPr; lower panel).
Figure 2
Figure 2. A novel acceptor of PAR from tankyrase 1 in mitosis
(A) A novel acceptor of PAR co-immunoprecipitates with tankyrase 1. Extracts generated in TNE buffer from nocodazole-arrested HeLa.I.2.11 cells were immunoprecipitated (IP) with control IgG (C) or anti-tankyrase 1 antibody (Ab) 465 (TNKS1), and incubated in a PARP assay with [32P]NAD+. Products were detected by immunoblotting with anti-tankyrase 1 antibody 465 (TNKS1; upper panel) or by autoradiography (32P-ADPr; lower panel); *** indicates the novel acceptor. (B) NuMA co-immunoprecipitates with tankyrase 1. Extracts were immunoprecipitated as in (A) and products detected by immunoblotting with anti-tankyrase 1 antibody 465 or anti-NuMA. (C) NuMA is PARsylated. Extracts generated in TNE buffer from nocodazole-arrested cells were immunoprecipitated with control serum (C) or anti-NuMA and incubated in a PARP assay with [32P]NAD+. Products were detected by immunoblotting with anti-NuMA (top panel) or anti-tankyrase 1 antibody 465 (TNKS1; middle panel) or by autoradiography (32P-ADPr; bottom panel). (D) NuMA is PARsylated by recombinant tankyrase 1, not PARP1. NuMA was immunoprecipitated as in (C) and incubated in a PARP assay with [32P]NAD+ in the absence (−) or presence (+) of 2.5 μg of recombinant PARP1 or TNKS1. Products were detected by autoradiography. (E) PARsylation of NuMA is stimulated by NAD+ and inhibited by 3AB. NuMA was immunoprecipitated as in (C) and incubated in a PARP assay with [32P]NAD+ in the absence (−) or presence (+) of 2.5 μg of recombinant TNKS1 and increasing amounts of unlabelled NAD+ (0.04, 0.2 or 1 mM) or 3AB (1 or 10 mM). Products were detected by autoradiography.
Figure 3
Figure 3. NuMA is PARsylated in mitotic cells
(A) NuMA immunoprecipitated from mitotic cells is PARsylated. Extracts generated in buffer C from asynchronous (asy) or nocodazole (noc)-arrested HeLaI.2.11 cells were analysed directly (input) or immunoprecipitated (IP) with control serum (−) or anti-NuMA antibodies (Ab) (+). Products were detected by immunoblotting with anti-NuMA, anti-tankyrase 1 465 (TNKS1) or anti-PAR antibodies. (B) Tankyrase 1 immunoprecipitates from mitotic cells contain PARsylated NuMA. Extracts generated as in (A) were analysed directly (Input) or immunoprecipitated with control IgG (−) or anti-tankyrase 1 antibody 465 (+). Products were detected by immunoblotting with anti-tankyrase 1 465 (TNKS1), anti-NuMA or anti-PAR.
Figure 4
Figure 4. Tankyrase 1 associates with and PARsylates NuMA at the onset of mitosis
(A, B) Analysis of staged cell cycle extracts. Following arrest in S phase by a double thymidine block, HeLaI.2.11 cells were released into nocodazole for 12 h, collected by shake-off and released out of nocodazole for 3 h. (A) FACS analysis of staged extracts: y axis, cell numbers; x axis, relative DNA content based on propidium iodide staining. (B) Staged cell extracts generated in buffer C were analysed directly (Input) or immunoprecipitated (IP) with anti-NuMA. Products were detected by immunoblotting with anti-NuMA, anti-tankyrase 1 antibody 465 (TNKS1) or anti-PAR. Cell cycle stages S, G2/M and G1 as determined by FACS as in (A) are indicated. (C) PARsylation of NuMA does not depend on nocodazole. Extracts generated in buffer C from asynchronous (asy) or from mitotic shake-off 8–9 h after release from a double thymidine block (shake-off) were immunoprecipitated with control serum (−) or anti-NuMA antibodies (Ab) (+). Products were detected by immunoblotting with anti-NuMA, anti-tankyrase 1 antibody 465 (TNKS1) or anti-PAR.
Figure 5
Figure 5. Immunofluorescence analysis indicates co-localization of NuMA and tankyrase 1 from prophase through to anaphase
Cycling cells were methanol-fixed and stained with anti-tankyrase 1 antibody 609 (green) and anti-NuMA antibody 1F1 (red). DAPI staining of the DNA is blue. Co-localization is indicated as yellow in the merged images. Cell cycle stage is indicated at the top. Bar=5 μm.
Figure 6
Figure 6. Tankyrase 1 is required for PARsylation of NuMA, but not for localization of NuMA to spindle poles
(A) NuMA localizes to spindle poles in the absence of tankyrase 1. Immunofluorescence analysis of methanol-fixed HeLaI.2.11 cells is shown after 48 h of transfection with tankyrase 1 siRNA. Cells were stained with anti-tankyrase 1 antibody 609 (TNKS1; green) (a and b) or anti-NuMA 1F1 (red) (a′ and b′). DAPI staining of the DNA is in blue. Bar=5 μm. (B) siRNA of tankyrase 1 eliminates PARsylation of NuMA in mitosis. Cells were incubated with (+) or without (−) tankyrase 1 siRNA for 48 h and treated with nocodazole for 24 h prior to harvesting. Extracts generated in buffer C were immunoprecipitated (IP) with control serum (−) or anti-NuMA antibodies (ab) (+). Products were detected by immunoblotting with anti-NuMA (top panel), anti-tankyrase 1 antibody 465 (TNKS1; middle panel), or anti-PAR (bottom panel). The asterisk (*) indicates a NuMA breakdown product described previously [55,56]. (C) Knockdown of NuMA results in loss of tankyrase 1 at spindle poles. Immunofluorescence analysis of methanol-fixed HeLaI.2.11 cells is shown after 48 h of transfection with NuMA siRNA. Cells were stained with anti-NuMA antibody 1F1 (red) (a and b) or anti-tankyrase 1 antibody 609 (TNKS1; green) (a′ and b′). DAPI staining of the DNA is in blue. Bar=5 μm. (D) Immunoblot analysis of HeLa.I.2.11 cells mock transfected (−) or transfected with NuMA siRNA (+) for 48 h. Cell extracts were generated in buffer C and proteins were detected by immunoblotting with anti-NuMA, anti-tankyrase 1 465 (TNKS1) or anti-α-tubulin antibodies.

Comment in

Similar articles

Cited by

References

    1. Smith S., Giriat I., Schmitt A., de Lange T. Tankyrase, a poly(ADP-ribose) polymerase at human telomeres. Science. 1998;282:1484–1487. - PubMed
    1. Cook B. D., Dynek J. N., Chang W., Shostak G., Smith S. Role for the related poly(ADP-ribose) polymerases tankyrase 1 and 2 at human telomeres. Mol. Cell. Biol. 2002;22:332–342. - PMC - PubMed
    1. Smith S., de Lange T. Tankyrase promotes telomere elongation in human cells. Curr. Biol. 2000;10:1299–1302. - PubMed
    1. Dynek J. N., Smith S. Resolution of sister telomere association is required for progression through mitosis. Science. 2004;304:97–100. - PubMed
    1. de Lange T. Protection of mammalian telomeres. Oncogene. 2002;21:532–540. - PubMed

Publication types